Mark W. Lingen

13.0k total citations · 1 hit paper
175 papers, 7.6k citations indexed

About

Mark W. Lingen is a scholar working on Molecular Biology, Otorhinolaryngology and Oncology. According to data from OpenAlex, Mark W. Lingen has authored 175 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 58 papers in Otorhinolaryngology and 49 papers in Oncology. Recurrent topics in Mark W. Lingen's work include Head and Neck Cancer Studies (58 papers), Angiogenesis and VEGF in Cancer (26 papers) and Oral Health Pathology and Treatment (24 papers). Mark W. Lingen is often cited by papers focused on Head and Neck Cancer Studies (58 papers), Angiogenesis and VEGF in Cancer (26 papers) and Oral Health Pathology and Treatment (24 papers). Mark W. Lingen collaborates with scholars based in United States, United Kingdom and Canada. Mark W. Lingen's co-authors include Paul M. Speight, Theodore Karrison, John R. Kalmar, Ezra E.W. Cohen, Peter J. Polverini, Everett E. Vokes, Rifat Hasina, Noël Bouck, Richard C. Jordan and Bayardo Perez‐Ordoñez and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Mark W. Lingen

170 papers receiving 7.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Critical evaluation of diagnostic aids for the detection of oral cancer

2007 503 citations Mark W. Lingen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark W. Lingen	2.8k	2.2k	2.0k	1.6k	1.3k	175	7.6k
Ricardo D. Coletta	3.8k 1.4×	1.1k 0.5×	1.9k 1.0×	1.2k 0.8×	751 0.6×	319	8.0k
Chuen Hsueh	2.3k 0.8×	1.6k 0.7×	2.1k 1.0×	2.9k 1.8×	957 0.7×	292	8.6k
Juan P. Rodrigo	2.4k 0.9×	3.7k 1.7×	3.7k 1.8×	4.3k 2.8×	2.0k 1.5×	411	10.3k
Corrado Rubini	2.4k 0.9×	623 0.3×	1.7k 0.8×	1.0k 0.7×	660 0.5×	261	6.2k
Ziv Gil	1.4k 0.5×	1.9k 0.9×	2.0k 1.0×	3.2k 2.0×	947 0.7×	169	6.9k
Gary L. Clayman	5.0k 1.8×	3.1k 1.4×	5.7k 2.8×	3.4k 2.2×	1.6k 1.2×	232	13.8k
Primož Strojan	1.1k 0.4×	3.1k 1.4×	2.5k 1.3×	3.1k 2.0×	1.9k 1.4×	244	7.9k
Susan Müller	1.1k 0.4×	818 0.4×	1.3k 0.7×	1.2k 0.7×	554 0.4×	117	4.5k
John D. Crissman	2.0k 0.7×	1.6k 0.7×	3.4k 1.7×	3.4k 2.2×	2.6k 2.0×	185	9.7k
Shiang‐Fu Huang	1.0k 0.4×	3.0k 1.4×	1.6k 0.8×	2.3k 1.5×	918 0.7×	194	5.1k

Countries citing papers authored by Mark W. Lingen

Since Specialization

Citations

This map shows the geographic impact of Mark W. Lingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Lingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Lingen more than expected).

Fields of papers citing papers by Mark W. Lingen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Lingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Lingen. The network helps show where Mark W. Lingen may publish in the future.

Co-authorship network of co-authors of Mark W. Lingen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Lingen. A scholar is included among the top collaborators of Mark W. Lingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Lingen. Mark W. Lingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenberg, Ari J., Aditya Juloori, Evgeny Izumchenko, et al.. (2024). Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV.. Journal of Clinical Oncology. 42(16_suppl). 6017–6017. 4 indexed citations

Rosenberg, Ari J., Evgeny Izumchenko, Aditya Juloori, et al.. (2023). 886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant chemotherapy and response-stratified treatment. Annals of Oncology. 34. S568–S568.

Lingen, Mark W., et al.. (2023). Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Oral Cavity Dysplasia: Why Does Histologic Grading Continue to be Contentious?. Head and Neck Pathology. 17(2). 292–298. 5 indexed citations

Chao, Jaime, Alex Zhavoronkov, Ivan V. Ozerov, et al.. (2021). Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma. Cell Reports Medicine. 2(9). 100399–100399. 15 indexed citations

Polverini, Peter J. & Mark W. Lingen. (2019). A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer. Journal of Dental Research. 98(5). 489–497. 10 indexed citations

Fakhry, Carole, Christina Lacchetti, Lisa M. Rooper, et al.. (2018). Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. Journal of Clinical Oncology. 36(31). 3152–3161. 166 indexed citations

Saloura, Vassiliki, Makda Zewde, Kazuma Kiyotani, et al.. (2017). Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 23(16). 4897–4907. 20 indexed citations

Bao, Riyue, Pieter Faber, Vytautas P. Bindokas, et al.. (2015). Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis. Cancer Research. 75(18). 3958–3969. 24 indexed citations

Brand, Toni M., Mari Iida, Andrew P. Stein, et al.. (2015). AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 21(11). 2601–2612. 89 indexed citations

10.

Saloura, Vassiliki, Hyun‐Soo Cho, Kazuma Kiyotani, et al.. (2014). WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck. Molecular Cancer Research. 13(2). 293–304. 83 indexed citations

11.

Lingen, Mark W.. (2011). Brush-based Cytology Screening in the Tonsils and Cervix: There Is a Difference!. Cancer Prevention Research. 4(9). 1350–1352. 25 indexed citations

12.

Glubb, Dylan M., Elisa Cerri, Wei Zhang, et al.. (2011). Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer. Clinical Cancer Research. 17(16). 5257–5267. 65 indexed citations

13.

Cohen, Ezra E.W., Daniel J. Haraf, Rangesh Kunnavakkam, et al.. (2010). Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 28(20). 3336–3343. 64 indexed citations

14.

Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Leonardo Faoro, et al.. (2009). The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research. 69(7). 3021–3031. 211 indexed citations

15.

Neiva, Kathleen G., et al.. (2009). VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death and Differentiation. 17(3). 499–512. 158 indexed citations

16.

Cohen, Ezra E.W., Hongyan Zhu, Mark W. Lingen, et al.. (2008). A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle. Cancer Research. 69(1). 65–74. 67 indexed citations

17.

Cohen, Ezra E.W., Mark W. Lingen, Bangmin Zhu, et al.. (2006). Protein Kinase Cζ Mediates Epidermal Growth Factor–Induced Growth of Head and Neck Tumor Cells by Regulating Mitogen-Activated Protein Kinase. Cancer Research. 66(12). 6296–6303. 63 indexed citations

18.

Moss, Jonathan, et al.. (2006). Morphine-induced angiogenesis is blocked by methylnaltrexone. Cancer Research. 66. 228–228. 1 indexed citations

19.

Cohen, Ezra E.W., Mark W. Lingen, Michael Straza, et al.. (2006). Protein kinase C Zeta mediates EGF-induced growth of head and neck tumor cells by regulating MAP kinase. Cancer Research. 66. 17–17. 1 indexed citations

20.

Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Maria Tretiakova, et al.. (2005). Inhibition of c-Met signaling by SU11274 in head and neck squamous cell carcinoma (HNSCC). Cancer Research. 65. 1405–1405. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact